BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19139739)

  • 21. Haematopoietic stem cell transplantation for autoimmune disorders.
    Saccardi R; Di Gioia M; Bosi A
    Curr Opin Hematol; 2008 Nov; 15(6):594-600. PubMed ID: 18832930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
    Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
    Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation.
    Heemskerk MB; Cornelissen JJ; Roelen DL; van Rood JJ; Claas FH; Doxiadis II; Oudshoorn M
    Bone Marrow Transplant; 2007 Aug; 40(3):193-200. PubMed ID: 17529995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second allogeneic stem cell transplantation in myeloid malignancies.
    Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
    Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience.
    Castagnola E; Bagnasco F; Faraci M; Caviglia I; Caruso S; Cappelli B; Moroni C; Morreale G; Timitilli A; Tripodi G; Lanino E; Haupt R
    Bone Marrow Transplant; 2008 Feb; 41(4):339-47. PubMed ID: 18026151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune-related late-onset hemorrhagic cystitis post allogeneic hematopoietic stem cell transplantation.
    Huang XJ; Liu DH; Xu LP; Zhang HY; Liu KY
    Chin Med J (Engl); 2008 Sep; 121(18):1766-9. PubMed ID: 19080354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan.
    Kinugawa N; Imashuku S; Hirota Y; Yamada K; Yamamoto A; Akazai A; Oda M; Miura N; Kakuta H; Sato T; Endo M; Takano T
    Bone Marrow Transplant; 1999 Oct; 24(8):935-8. PubMed ID: 10516710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation.
    Gotoh K; Ito Y; Shibata-Watanabe Y; Kawada J; Takahashi Y; Yagasaki H; Kojima S; Nishiyama Y; Kimura H
    Clin Infect Dis; 2008 May; 46(10):1525-34. PubMed ID: 18419486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haematopoietic stem cell transplantation for immune thrombopenia and other refractory autoimmune cytopenias.
    Passweg JR
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):305-15. PubMed ID: 15302342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living-donor lobar lung transplantation for pulmonary complications after hematopoietic stem cell transplantation.
    Yamane M; Sano Y; Toyooka S; Okazaki M; Date H; Oto T
    Transplantation; 2008 Dec; 86(12):1767-70. PubMed ID: 19104419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
    Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
    Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous stem cell transplantation in autoimmune diseases.
    Passweg J; Tyndall A
    Semin Hematol; 2007 Oct; 44(4):278-85. PubMed ID: 17961728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBMT activity survey 2004 and changes in disease indication over the past 15 years.
    Gratwohl A; Baldomero H; Frauendorfer K; Urbano-Ispizua A; ;
    Bone Marrow Transplant; 2006 Jun; 37(12):1069-85. PubMed ID: 16757972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
    Nevill TJ; Shepherd JD; Sutherland HJ; Abou Mourad YR; Lavoie JC; Barnett MJ; Nantel SH; Toze CL; Hogge DE; Forrest DL; Song KW; Power MM; Nitta JY; Dai Y; Smith CA
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):205-13. PubMed ID: 19167680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.
    Giebel S; Labopin M; Holowiecki J; Labar B; Komarnicki M; Koza V; Masszi T; Mistrik M; Lange A; Hellmann A; Vitek A; Pretnar J; Mayer J; Rzepecki P; Indrak K; Wiktor-Jedrzejczak W; Wojnar J; Krawczyk-Kulis M; Kyrcz-Krzemien S; Rocha V
    Ann Hematol; 2009 Oct; 88(10):1005-13. PubMed ID: 19301005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients.
    Mynarek M; Tolar J; Albert MH; Escolar ML; Boelens JJ; Cowan MJ; Finnegan N; Glomstein A; Jacobsohn DA; Kühl JS; Yabe H; Kurtzberg J; Malm D; Orchard PJ; Klein C; Lücke T; Sykora KW
    Bone Marrow Transplant; 2012 Mar; 47(3):352-9. PubMed ID: 21552297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-Hodgkin lymphoma and mature B-cell leukemia: a retrospective analysis of enrolled cases in Japan.
    Fujita N; Mori T; Mitsui T; Inada H; Horibe K; Tsurusawa M;
    Pediatr Blood Cancer; 2008 Aug; 51(2):188-92. PubMed ID: 18428432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.